Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome
Aim. To determine the efficacy and safety of Kolofort in the treatment of patients with irritable bowel syndrome (IBS). Subjects and methods. 52 patients (16 men and 36 women) aged 26 to 59 years were examined over 4 months to rule out organic disease. The diagnosis of IBS was established on the bas...
Main Authors: | V V Tsukanov, O S Rzhavicheva, A V Vasjutin, O V Dunaevskaja, Ju L Tonkih, E P Bronnikova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2016-08-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/32063/pdf |
Similar Items
-
Experience in the Treatment of Irritable Bowel Syndrome Developed after a New Coronavirus Infection (COVID-19)
by: R. G. Myazin
Published: (2022-05-01) -
COVID-19 Pandemic and Irritable Bowel Syndrome — is there a Relationship?
by: V. A. Akhmedov
Published: (2022-08-01) -
Efficacy of Kolofort in Combined Functional Gastroenterological Pathology: an Open Study
by: Yu. P. Uspenskiy, et al.
Published: (2020-12-01) -
Role of antispasmodics in the treatment of irritable bowel syndrome
by: V. N. Drozdov, et al.
Published: (2021-05-01) -
Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date
by: Nanayakkara WS, et al.
Published: (2016-06-01)